Cargando…

Beneficial effects of astragaloside IV against angiotensin II-induced mitochondrial dysfunction in rat vascular smooth muscle cells

Angiotensin II (Ang II)-induced mitochondrial dysfunction is a prominent characteristic of the majority of cardiovascular diseases. Astragaloside IV (As-IV), the major active ingredient of Astragalus membranaceus (Fisch.) Bge. (a traditional Chinese herbal medicine), possesses antioxidant properties...

Descripción completa

Detalles Bibliográficos
Autores principales:	LU, YAO, LI, SU, WU, HENGFANG, BIAN, ZHIPING, XU, JINDAN, GU, CHUNRONG, CHEN, XIANGJIAN, YANG, DI
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2015
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4601744/ https://www.ncbi.nlm.nih.gov/pubmed/26398547 http://dx.doi.org/10.3892/ijmm.2015.2345

Ejemplares similares

The Effect of Iron Oxide Magnetic Nanoparticles on Smooth Muscle Cells
por: Zhang, Song, et al.
Publicado: (2008)

Astragaloside IV alleviates senescence of vascular smooth muscle cells through activating Parkin-mediated mitophagy
por: Li, Huijun, et al.
Publicado: (2022)

In Vitro Effects of Hollow Gold Nanoshells on Human Aortic Endothelial Cells
por: Gu, Chunrong, et al.
Publicado: (2016)

The cytotoxicity evaluation of magnetic iron oxide nanoparticles on human aortic endothelial cells
por: Ge, Gaoyuan, et al.
Publicado: (2013)

High-fat diet causes mitochondrial damage and downregulation of mitofusin-2 and optic atrophy-1 in multiple organs
por: Zheng, Peng, et al.
Publicado: (2023)

Effect of berberine on PPAR(α)-NO signalling pathway in vascular smooth muscle cell proliferation induced by angiotensin IV
por: Qiu, Hongmei, et al.
Publicado: (2016)

Astragaloside IV inhibits platelet-derived growth factor-BB-stimulated proliferation and migration of vascular smooth muscle cells via the inhibition of p38 MAPK signaling
por: CHEN, ZHUO, et al.
Publicado: (2014)

Pharmacological Effects of Astragaloside IV: A Review
por: Liang, Yutong, et al.
Publicado: (2023)

Anticancer effects and mechanisms of astragaloside-IV
por: Zhou, Liangxing, et al.
Publicado: (2022)

Astragaloside IV Improves Metabolic Syndrome and Endothelium Dysfunction in Fructose-Fed Rats
por: Zhang, Ning, et al.
Publicado: (2011)

[Retracted] Astragaloside IV inhibits platelet‑derived growth factor‑BB‑stimulated proliferation and migration of vascular smooth muscle cells via the inhibition of p38 MAPK signaling
por: Chen, Zhuo, et al.
Publicado: (2023)

Astragaloside IV ameliorates diabetic nephropathy by modulating the mitochondrial quality control network
por: Liu, Xinhui, et al.
Publicado: (2017)

Mitochondrial K(ATP) channel involvement in angiotensin II-induced autophagy in vascular smooth muscle cells
por: Yu, Kang-Ying, et al.
Publicado: (2014)

Beneficial Effects of Astragaloside IV for Hair Loss via Inhibition of Fas/Fas L-Mediated Apoptotic Signaling
por: Kim, Mi Hye, et al.
Publicado: (2014)

Vascular smooth muscle cell dysfunction in neurodegeneration
por: Hayes, Genevieve, et al.
Publicado: (2022)

Functional angiotensin II receptors in cultured vascular smooth muscle cells
Publicado: (1982)

Effects of Astragaloside IV on heart failure in rats
por: Zhao, Zhuanyou, et al.
Publicado: (2009)

Effects of astragaloside IV on the pharmacokinetics of omeprazole in rats
por: Liu, Wei, et al.
Publicado: (2019)

Astragaloside IV, as a potential anticancer agent
por: Xia, Dongqin, et al.
Publicado: (2023)

Astragaloside IV Alleviates Infarction Induced Cardiomyocyte Injury by Improving Mitochondrial Morphology and Function
por: Zhang, Wen, et al.
Publicado: (2022)

Different Effects of Angiotensin II and Angiotensin-(1-7) on Vascular Smooth Muscle Cell Proliferation and Migration
por: Zhang, Feng, et al.
Publicado: (2010)

Astragaloside IV alleviates heart failure by regulating SUMO-specific protease 1
por: Liu, Juan, et al.
Publicado: (2021)

Astragaloside IV attenuates hypoxia-induced pulmonary vascular remodeling via the Notch signaling pathway
por: Yao, Jiamei, et al.
Publicado: (2021)

Astragaloside IV attenuates hypoxia-induced pulmonary vascular remodeling via the Notch signaling pathway
por: Yao, Jiamei, et al.
Publicado: (2022)

Astragaloside IV Alleviates Intestinal Barrier Dysfunction via the AKT-GSK3β-β-Catenin Pathway in Peritoneal Dialysis
por: He, Jiaqi, et al.
Publicado: (2022)

Angiotensin II, Hypercholesterolemia, and Vascular Smooth Muscle Cells: A Perfect Trio for Vascular Pathology
por: St. Paul, Amanda, et al.
Publicado: (2020)

Angiotensin II-Regulated Autophagy Is Required for Vascular Smooth Muscle Cell Hypertrophy
por: Mondaca-Ruff, David, et al.
Publicado: (2019)

Molecular Mechanism of Astragaloside IV in Improving Endothelial Dysfunction of Cardiovascular Diseases Mediated by Oxidative Stress
por: Meng, Peipei, et al.
Publicado: (2021)

Astragaloside IV ameliorates fat metabolism in the liver of ageing mice through targeting mitochondrial activity
por: Luo, Zhixiao, et al.
Publicado: (2021)

The mechanism of astragaloside IV promoting sciatic nerve regeneration
por: Zhang, Xiaohong, et al.
Publicado: (2013)

Astragaloside IV: An Effective Drug for the Treatment of Cardiovascular Diseases
por: Tan, Yu-Qing, et al.
Publicado: (2020)

Molecular mechanisms of astragaloside-IV in cancer therapy (Review)
por: Chen, Tianqi, et al.
Publicado: (2021)

Roles and Mechanisms of Astragaloside IV in Combating Neuronal Aging
por: Zaman, Qumar, et al.
Publicado: (2022)

Research progress on the mechanism of astragaloside IV in the treatment of asthma
por: Yuan, Fanyi, et al.
Publicado: (2023)

[Corrigendum] Astragaloside IV alleviates heart failure by regulating SUMO‑specific protease 1
por: Liu, Juan, et al.
Publicado: (2023)

Astragaloside IV prevents endothelial dysfunction by improving oxidative stress in streptozotocin-induced diabetic mouse aortas
por: Zhang, Yang, et al.
Publicado: (2021)

Regulation of angiotensin II actions by enhancers and super-enhancers in vascular smooth muscle cells
por: Das, Sadhan, et al.
Publicado: (2017)

Regulation of total LC3 levels by angiotensin II in vascular smooth muscle cells
por: Mondaca‐Ruff, David, et al.
Publicado: (2022)

Mitochondrial metabolism and the control of vascular smooth muscle cell proliferation
por: Chiong, Mario, et al.
Publicado: (2014)

Protective effect of Astragaloside IV on chronic intermittent hypoxia-induced vascular endothelial dysfunction through the calpain-1/SIRT1/AMPK signaling pathway
por: Zhao, Fang, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_cd9eo420q1n43p4n833g7gpu68